YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Cyclosporine Reduces Hepatic Antioxidant Capacity

dc.authorid Elgun, Serenay/0000-0002-1751-090X
dc.authorscopusid 7005916873
dc.authorscopusid 7005912992
dc.authorscopusid 6701749734
dc.authorwosid Elgun, Serenay/Aag-9070-2020
dc.authorwosid Ozbek, Hanefi/O-3472-2019
dc.contributor.author Durak, I
dc.contributor.author Özbek, H
dc.contributor.author Elgün, S
dc.date.accessioned 2025-05-10T17:39:17Z
dc.date.available 2025-05-10T17:39:17Z
dc.date.issued 2004
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Ankara Univ, Tip Fak, Dept Biochem, Biyokimya ABD Dekanlik Binasi, TR-06100 Ankara, Turkey; Yil Univ 100, Sch Med, Dept Pharmacol, Van, Turkey en_US
dc.description Elgun, Serenay/0000-0002-1751-090X en_US
dc.description.abstract The immunosuppressive agent cyclosporine A (CsA) has been reported to exert measurable hepatotoxic effects. One of the causes leading to hepatotoxicity is thought to be reactive oxygen radical formation. Therefore, this study was designed to elucidate possible relation between cyclosporine A treatment and antioxidant capacity (AOC) of hepatic tissue and, to determine if antioxidant supplementation is beneficial. Cyclosporine A was given to 20 rabbits orally for 10 days. Vitamins E and C combination were given intramuscularly. Vitamin therapy was started 3 days before cyclosporine A treatment and continued for 10 days. In each group (control, cyclosporine A, cyclosporine A+ vitamin, and vitamin only) there were five animals. After the animals were sacrificed, their livers were removed to be used in the AOC measurement. AOC was found to be lower in cyclosporine A group compared to control and vitamin groups. Results suggest that reduced antioxidant capacity may play part in the cyclosporine A-induced hepatotoxicity and use of some antioxidants may give beneficial results. (C) 2004 Published by Elsevier B.V. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1016/j.intimp.2004.01.018
dc.identifier.endpage 473 en_US
dc.identifier.issn 1567-5769
dc.identifier.issn 1878-1705
dc.identifier.issue 3 en_US
dc.identifier.pmid 15037224
dc.identifier.scopus 2-s2.0-1642282731
dc.identifier.scopusquality Q2
dc.identifier.startpage 469 en_US
dc.identifier.uri https://doi.org/10.1016/j.intimp.2004.01.018
dc.identifier.uri https://hdl.handle.net/20.500.14720/14825
dc.identifier.volume 4 en_US
dc.identifier.wos WOS:000220571400015
dc.identifier.wosquality Q1
dc.language.iso en en_US
dc.publisher Elsevier Science Bv en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Cyclosporine en_US
dc.subject Liver en_US
dc.subject Antioxidant Capacity en_US
dc.subject Peroxidation en_US
dc.title Cyclosporine Reduces Hepatic Antioxidant Capacity en_US
dc.type Article en_US

Files